424
Views
58
CrossRef citations to date
0
Altmetric
Reviews

Promising alternative settings for HPV vaccination of US adolescents

, , , &
Pages 235-246 | Published online: 03 Jan 2014

References

  • Smith JS, Lindsay L, Hoots B, et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer 2007;121(3):621-32
  • Lowy DR, Schiller JT. Reducing HPV-associated cancer globally. Cancer Prev Res 2012;5(1):18-23
  • Newmann SJ, Garner EO. Social inequities along the cervical cancer continuum: a structured review. Cancer Causes Control 2005;16(1):63-70
  • Markowitz LE, Dunne E, Saraiya M, et al. Quadrivalent human papillomavirus vaccine. MMWR Morb Mortal Wkly Rep 2007;56(RR02):1-24
  • Dunne E, Markowitz L, Chesson H, et al. Recommendations on the use of quadrivalent human papillomavirus vaccine in males–Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep 2011;60(50):1705-8
  • Centers for Disease Control and Prevention (CDC). 2012. NIS-Teen Vaccination Coverage Table Data. 2013. Available from: http://www.cdc.gov/vaccines/stats-surv/nisteen/tables/12/tab01_iap_2012.pdf
  • Tan W, Viera AJ, Rowe-West B, et al. The HPV vaccine: are dosing recommendations being followed? Vaccine 2011;29(14):2548-54
  • Strickland BB, Jones JR, Ghandour RM, et al. The medical home: health care access and impact for children and youth in the United States. Pediatrics 2011;127(4):604-11
  • Bodenheimer T, Pham HH. Primary care: current problems and proposed solutions. Health Aff 2010;29(5):799-805
  • Elster A, Jarosik J, VanGeest J, Fleming M. Racial and ethnic disparities in health care for adolescents: a systematic review of the literature. Arch Pediatr Adolesc Med 2003;157(9):867-74
  • Newacheck PW, Hung YY, Jane Park M, et al. Disparities in adolescent health and health care: does socioeconomic status matter? Health Serv Res 2003;38(5):1235-52
  • President’s Cancer Panel. Accelerating HPV vaccine uptake: urgency for action to prevent cancer. President’s Cancer Panel Annual Report 2012-2013; National Institutes of Health (2013)
  • Schaffer SJ, Fontanesi J, Rickert D, et al. How effectively can health care settings beyond the traditional medical home provide vaccines to adolescents? Pediatrics 2008;121(Suppl 1):S35-45
  • Rand CM, Shone LP, Albertin C, et al. National health care visit patterns of adolescents: implications for delivery of new adolescent vaccines. Arch Pediatr Adolesc Med 2007;161(3):252-9
  • Marcell AV, Klein JD, Fischer I, et al. Male adolescent use of health care services: where are the boys? J Adolesc Health 2002;30(1):35-43
  • Clevenger L, Pyrzanowski J, Curtis CR, et al. Parents’ acceptance of adolescent immunizations outside of the traditional medical home. J Adolesc Health 2011;49(2):133-40
  • Klein JD, McNulty M, Flatau CN. Adolescents’ access to care: teenagers’ self-reported use of services and perceived access to confidential care. Arch Pediatr Adolesc Med 1998;152(7):676
  • Rand CM, Szilagyi PG, Albertin C, Auinger P. Additional health care visits needed among adolescents for human papillomavirus vaccine delivery within medical homes: a national study. Pediatrics 2007;120(3):461-6
  • Gerend MA, Weibley E, Bland H. Parental response to human papillomavirus vaccine availability: uptake and intentions. J Adolesc Health 2009;45(5):528-31
  • Reiter PL, Brewer NT, Gottlieb SL, et al. Parents’ health beliefs and HPV vaccination of their adolescent daughters. Soc Sci Med 2009;69(3):475-80
  • Allen JD, Othus MK, Shelton RC, et al. Parental decision making about the HPV vaccine. Cancer Epidemiol Biomarkers Prev 2010;19(9):2187-98
  • Brewer NT, Gottlieb SL, Reiter PL, et al. Longitudinal predictors of human papillomavirus vaccine initiation among adolescent girls in a high-risk geographic area. Sex Transm Dis 2011;38(3):197-204
  • Rosenthal SL, Weiss TW, Zimet GD, et al. Predictors of HPV vaccine uptake among women aged 19–26: importance of a physician’s recommendation. Vaccine 2011;29(5):890-5
  • Lau M, Lin H, Flores G. Factors associated with human papillomavirus vaccine-series initiation and healthcare provider recommendation in US adolescent females. 2007 National Survey of Children’s Health. Vaccine 2012;30(20):3112-18
  • Dorell C, Stokley S, Yankey D, et al. National and state vaccination coverage among adolescents aged 13-17 Years–United States. 2011. MMWR Morb Mortal Wkly Rep 2012;61:671-7
  • Hughes CC, Jones AL, Feemster KA, Fiks AG. HPV vaccine decision making in pediatric primary care: a semi-structured interview study. BMC Pediatr 2011;11:74
  • Hamlish T, Clarke L, Alexander KA. Barriers to HPV immunization for African American adolescent females. Vaccine 2012;30(45):6472-6
  • Stokley S, Curtis CR, Jeyarajah J, et al. Human papillomavirus vaccination coverage among adolescent girls, 2007–2012, and postlicensure vaccine safety monitoring, 2006–2013 – United States. MMWR Morb Mortal Wkly Rep 2013;62(29):591-5
  • Bynum SA, Staras SA, Malo TL, et al. Factors associated with Medicaid providers’ recommendation of the HPV vaccine to low-income adolescent girls. J Adolesc Health 2013; In press
  • Dempsey AF, Davis MM. Overcoming barriers to adherence to. HPV vaccination recommendations. Am J Manag Care 2006;12(17 Suppl):S484-91
  • Vadaparampil ST, Kahn JA, Salmon D, et al. Missed clinical opportunities: provider recommendations for HPV vaccination for 11-12 year old girls are limited. Vaccine 2011;29(47):8634-41
  • Szilagyi PG, Rand CM, McLaurin J, et al. Delivering adolescent vaccinations in the medical home: a new era? Pediatrics 2008;121(Suppl 1):S15-24
  • Gilkey MB, Moss JL, McRee AL, Brewer NT. Do correlates of HPV vaccine initiation differ between adolescent boys and girls? Vaccine 2012;30(41):5928-34
  • Campos-Outcalt D, Jeffcott-Pera M, Carter-Smith P, et al. Vaccines provided by family physicians. Ann Fam Med 2010;8(6):507-10
  • Reiter PL, McRee A, Pepper JK, et al. Improving human papillomavirus vaccine delivery: a national study of parents and their adolescent sons. J Adolesc Health 2012;51(1):32-7
  • Katz ML, Reiter PL, Kluhsman BC, et al. Human papillomavirus (HPV) vaccine availability, recommendations, cost, and policies among health departments in seven Appalachian states. Vaccine 2009;27(24):3195-200
  • Centers for Disease Control and Prevention (CDC). HPV Vaccine - Questions & Answers. 2012. Available from http://www.cdc.gov/vaccines/vpd-vac/hpv/vac-faqs.htm
  • The American Pharmacists Association. Every month should be immunization month...Until everyone is vaccinated. Adapted from a document presented to HHS Secretary Shalala and the National Vaccination Program Office; Washington, DC, USA; 1994
  • Knapp KK. Building a pharmacy work force mosaic: new studies help to fill in the gaps. J Am Pharm Assoc 2000;40(1):13-14
  • Bureau of Labor Statistics, US Department of Labor. Occupational outlook handbook 2012-2013: pharmacists. 2012. Available from: http://www.bls.gov/oes/current/oes291051.htm
  • Pilisuk T, Goad J, Backer H. Vaccination delivery by chain pharmacies in California: results of a. 2007 survey. J Am Pharm Assoc 2010;50(2):134-9
  • Manolakis PG, Skelton JB. Pharmacists’ contributions to primary care in the United States collaborating to address unmet patient care needs: the emerging role for pharmacists to address the shortage of primary care providers. Am J Pharm Educ 2010;74(10):1
  • Gallup. Honesty/ethics in professions. 2012. Available from: http://www.gallup.com/poll/1654/honesty-ethics-professions.aspx
  • McRee A, Reiter PL, Pepper JK, Brewer NT. Correlates of comfort with alternative settings for HPV vaccine delivery. Hum Vaccin Immunother 2013;9(2):42-9
  • Rosenbluth SA, Madhavan SS, Borker RD, Maine LL. Pharmacy immunization partnerships: a rural model. J Am Pharm Assoc 2001;41(1):100-7
  • Ndiaye SM, Madhavan S, Washington ML, et al. The use of pharmacy immunization services in rural communities. Public Health 2003;117(2):88-97
  • Fontanesi J, Hirsch J, Lorentz S, et al. Comparison of pharmacists and primary care providers as immunizers. Am J Pharm Benefits 2009;1(3):50-7
  • McIntosh J, Sturpe DA, Khanna N. Human papillomavirus vaccine and cervical cancer prevention: practice and policy implications for pharmacists. J Am Pharm Assoc 2008;48(1):e1-17
  • Romanelli F, Freeman T. Immunization training: right or privilege? Am J Pharm Educ 2012;76(4):1
  • Brewer NT, Chung JK, Baker HM, Smith JS. Pharmacist immunization authority for HPV, Tdap, and meningococcal vaccines. Under review 2013
  • Committee on Practice and Ambulatory Medicine and Council on Community Pediatrics. Increasing immunization coverage. Pediatrics 2010;125(6):1295-304
  • Lofink H, Kuebler J, Juszczak L, et al. 2010-2011 School-Based Health Alliance Census Report. 2013. Available from: http://www.sbh4all.org/atf/cf/%7BB241D183-DA6F-443F-9588-3230D027D8DB%7D/2010-11%20Census%20Report%20Final.pdf
  • Brener ND, Wheeler L, Wolfe LC, et al. Health services: results from the school health policies and programs study 2006. J Sch Health 2007;77(8):464-85
  • School Based Health Alliance (SBHA). SBHC capital grant. 2012. Available from: http://www.sbh4all.org/site/c.ckLQKbOVLkK6E/b.7697107/apps/s/content.asp?ct=11666829
  • Federico SG, Abrams L, Everhart RM, et al. Addressing adolescent immunization disparities: a retrospective analysis of school-based health center immunization delivery. Am J Public Health 2010;100(9):1630
  • Lindley MC, Boyer-Chu L, Fishbein DB, et al. The role of schools in strengthening delivery of new adolescent vaccinations. Pediatrics 2008;121(Suppl 1):S46-54
  • Strozer J, Juszczak L, Ammerman A. 2007-2008 National School-based health care census. National Assembly on School-Based Health Care; Washington, DC: 2010
  • Daley MF, Curtis CR, Pyrzanowski J, et al. Adolescent immunization delivery in school-based health centers: a national survey. J Adolesc Health 2009;45(5):445-2
  • Moss JL, Leighton A, O’Malley B, et al. Opportunities for increasing HPV vaccine provision in school health centers. Submitted
  • Fiks AG, Grundmeier RW, Biggs LM, et al. Impact of clinical alerts within an electronic health record on routine childhood immunization in an urban pediatric population. Pediatrics 2007;120(4):707-14
  • Hayes KA, Entzel P, Berger W, et al. Early lessons learned from extramural school programs that offer HPV vaccine. J Sch Health 2013;83(2):119-26
  • US Census Bureau. School enrollment. 2013. Available from: http://www.census.gov/hhes/school/data/cps/2012/tables.html
  • Stretch R, Roberts S, McCann R, et al. Parental attitudes and information needs in an adolescent HPV vaccination programme. Br J Cancer 2008;99(11):1908-11
  • Reeve C, De La Rue S, Pashen D, et al. School-based vaccinations delivered by general practice in rural north Queensland: an evaluation of a new human papilloma virus vaccination program. Commun Dis Intell 2008;32(1):94
  • Watson M, Shaw D, Molchanoff L, McInnes C. Challenges, lessons learned and results following the implementation of a human papilloma virus school vaccination program in South Australia. Aust NZ J Public Health 2009;33(4):365-70
  • Brotherton JM, Fairley CK, Garland SM, et al. Closing editorial: processes, opportunities and challenges after introduction of human papillomavirus vaccine. Sex Health 2010;7(3):397-8
  • Ogilvie G, Anderson M, Marra F, et al. A population-based evaluation of a publicly funded, school-based HPV vaccine program in British Columbia, Canada: parental factors associated with HPV vaccine receipt. PLoS Med 2010;7(5):e1000270
  • Musto R, Siever JE, Johnston JC, et al. Social equity in Human Papillomavirus vaccination: a natural experiment in Calgary Canada. BMC Public Health 2013;13(1):640
  • Hollinger F. Comprehensive control (or elimination) of hepatitis B virus transmission in the United States. Gut 1996;38(Suppl 2):S24-30
  • King JC, Stoddard JJ, Gaglani MJ, et al. Effectiveness of school-based influenza vaccination. N Engl J Med 2006;355(24):2523-32
  • Effler PV, Chu C, He H, et al. Statewide school-located influenza vaccination program for children 5-13 years of age, Hawaii, USA. Emerg Infect Dis 2010;16(2):244-50
  • Vanderpool RC, Cohen EL, Crosby RA, et al. " 1–2–3 Pap" Intervention improves HPV vaccine series completion among Appalachian women. J Commun 2013;63(1):95-115
  • Cooper Robbins SC, Ward K, Skinner SR. School-based vaccination: a systematic review of process evaluations. Vaccine 2011;29(52):9588-99
  • Kadis JA, McRee A, Gottlieb SL, et al. Mothers’ support for voluntary provision of HPV vaccine in schools. Vaccine 2011;29(14):2542-7
  • Kelminson K, Saville A, Seewald L, et al. Parental views of school-located delivery of adolescent vaccines. J Adolesc Health 2012;51(2):190-6
  • Stubbs BW, Panozzo CA, Moss JL, et al. Evaluation of an intervention providing HPV vaccine in schools. Am J Health Behav 2014;38(1):92-102
  • Lott J, Johnson J. Promising practices for school-located vaccination clinics—part i: preparation. Pediatrics 2012;129(Suppl 2):S75-80
  • Nelson R. School nurses are needed more than ever. Am J Nurs 2009;109(12):25-7
  • Hoover KW, Tao G, Berman S, Kent CK. Utilization of health services in physician offices and outpatient clinics by adolescents and young women in the United States: implications for improving access to reproductive health services. J Adolesc Health 2010;46(4):324-30
  • Carlos RC, Dempsey AF, Patel DA, Dalton VK. Cervical cancer prevention through human papillomavirus vaccination: using the “teachable moment” for educational interventions. Obstet Gynecol 2010;115(4):834
  • Salz T, Gottlieb SL, Smith JS, Brewer NT. The association between cervical abnormalities and attitudes toward cervical cancer prevention. J Womens Health 2010;19(11):2011-16
  • Vitek WS, Akers A, Meyn LA, et al. Vaccine eligibility and acceptance among ambulatory obstetric and gynecologic patients. Vaccine 2011;29(11):2024-8
  • Perkins RB, Anderson BL, Gorin SS, Schulkin JA. Challenges in cervical cancer prevention: a survey of U.S. obstetrician-gynecologists. Am J Prev Med 2013;45(2):175-81
  • American College of Obstetricians and Gynecologists. Human papillomavirus vaccination. committee opinion No. 467. Obstet Gynecol 2010;116(3):800-3
  • Leddy MA, Anderson BL, Power ML, et al. Changes in and current status of obstetrician-gynecologists’ knowledge, attitudes, and practice regarding immunization. Obstet Gynecol Surv 2009;64(12):823-9
  • Schrag SJ, Fiore AE, Gonik B, et al. Vaccination and perinatal infection prevention practices among obstetrician–gynecologists. Obstet Gynecol 2003;101(4):704-10
  • Power ML, Leddy MA, Anderson BL, et al. Obstetrician–Gynecologists’ practices and perceived knowledge regarding immunization. Am J Prev Med 2009;37(3):231-4
  • Celum CL, Bolan G, Krone M, et al. Patients attending STD clinics in an evolving health care environment: demographics, insurance coverage, preferences for STD services, and STD morbidity. Sex Transm Dis 1997;24(10):599-605
  • Meites E, Llata E, Hariri S, et al. HPV vaccine implementation in STD clinics – STD surveillance network. Sex Transm Dis 2012;39(1):32-4
  • Cummingswilson B, Moyer L, Schmid G, et al. Hepatitis B vaccination in sexually transmitted disease (STD) clinics: a survey of STD programs. Sex Transm Dis 2001;28(3):148-52
  • Handsfield HH. Hepatitis A and B immunization in persons being evaluated for sexually transmitted diseases. Am J Med 2005;118(10):69-74
  • English A, Shaw FE, McCauley MM, Fishbein DB. Legal basis of consent for health care and vaccination for adolescents. Pediatrics 2008;121(Suppl 1):S85-7
  • Pyrzanowski J, Curtis CR, Crane LA, et al. Adolescents’ perspectives on vaccination outside the traditional medical home a survey of urban middle and high school students. Clin Pediatr 2013;52(4):329-37
  • Gilbert LK, Bulger J, Scanlon K, et al. Integrating hepatitis B prevention into sexually transmitted disease services: US sexually transmitted disease program and clinic trends-1997 and 2001. Sex Transm Dis 2005;32(6):346-50
  • Richardson LD, Asplin BR, Lowe RA. Emergency department crowding as a health policy issue: past development, future directions. Ann Emerg Med 2002;40(4):388-93
  • American College of Emergency Physicians, Pediatric Committee. Immunization of adults and children in the emergency department. Ann Emerg Med 2008;51(5):695
  • Pallin DJ, Muennig PA, Emond JA, et al. Vaccination practices in U.S. emergency departments, 1992–2000. Vaccine 2005;23(8):1048-52
  • Isong IA, Soobader M, Fisher-Owens SA, et al. Racial disparity trends in children’s dental visits: US national health interview survey, 1964–2010. Pediatrics 2012;130(2):306-14
  • Daley E, DeBate R, Dodd V, et al. Exploring awareness, attitudes, and perceived role among oral health providers regarding HPV-related oral cancers. J Public Health Dent 2011;71(2):136-42
  • Centers for Disease Control and Prevention (CDC). HPV vaccine: safe, effective, and grossly underutilized. 2013. Available from: http://www.cdc.gov/media/releases/2013/p0725-HPV-vaccine.html
  • Bugenske E, Stokley S, Kennedy A, Dorell C. Middle school vaccination requirements and adolescent vaccination coverage. Pediatrics 2012;129(6):1056-63
  • Smith JS, Brewer NT, Chang Y, et al. Acceptability of school requirements for human papillomavirus vaccine. Hum Vaccin 2011;7(9):952-7
  • Robitz R, Gottlieb SL, De Rosa CJ, et al. Parent attitudes about school requirements for human papillomavirus vaccine in high-risk communities of Los Angeles, California. Cancer Epidemiol Biomarkers Prev 2011;20(7):1421-9
  • Gilkey MB, Brewer NT. Mandatory HPV vaccination. JAMA 2012;307(3):252-3
  • Suh CA, Saville A, Daley MF, et al. Effectiveness and net cost of reminder/recall for adolescent immunizations. Pediatrics 2012;129(6):e1437-45
  • Singer DC, Davis MM, Gebremariam A, Clark SJ. Underinsurance for recently recommended vaccines in private health plans. J Community Health 2012;37(6):1164-7
  • Nevada Division of Public and Behavioral Health. Vaccines for Children Program. 2013. Available from: http://www.health.nv.gov/Vaccine_VFCProgram.htm
  • Centers for Disease Control and Prevention (CDC). WB2219—Immunization: you Call the Shots-Module Sixteen-Vaccines for Children Program. 2013. Available from: http://www2a.cdc.gov/nip/isd/ycts/mod1/courses/vfc/ce.asp
  • Merck Sharp & Dohme Corp. Merck’s Investigational 9-valent HPV Vaccine, V503, Prevented 97 Percent of Cervical, Vaginal and Vulvar Pre-cancers Caused by Five Additional HPV Types, in Phase III Study. 2013. Available from: http://www.mercknewsroom.com/news-release/research-and-development-news/mercks-investigational-9-valent-hpv-vaccine-v503-prevente
  • Cawley J, Hull HF, Rousculp MD. Strategies for implementing school‐located influenza vaccination of children: a systematic literature review. J Sch Health 2010;80(4):167-75
  • Golden SD, Moracco KE, Leighton A, et al. Process evaluation of an intervention to increase provision of adolescent vaccines at school health centers. J Sch Health; Under review
  • Robbins SCC, Bernard D, McCaffery K, Skinner SR. ’It’s a logistical nightmare!’ Recommendations for optimising human papillomavirus school-based vaccination experience. Sex Health 2010;7(3):271-8
  • Kent H, Heffernan ME, Silvers J, et al. Role of the nurse immunizer in implementing and maintaining the national human papillomavirus ’cervical cancer’ vaccine rollout through a school-based program in Victoria. Sex Health 2010;7(3):391-3

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.